Eli Lilly outpaces Novo in the GLP-1 market with Tirzepatide and emerging blockbusters, signaling future growth. Read more on ...

An obesity drug from Hengrui Pharma and Kailera Therapeutics succeeded in a late-stage trial in China, while Anne Wojcicki’s ...

In an interview with CBC News, Janie Mackenzie described the chaotic days that unfolded after six-year-old Lily Sullivan and ...

Lilly Pulitzer will be opening Lilly's Vintage Vault, which features the reintroduction of the brand's most popular archival ...

Eli Lilly is tagging along on actress Kym Whitley’s blockbuster summer in a fresh Zepbound partnership with the “Happy ...

Ilona Maher recently showed her support for fellow rugby player Georgie Lilly Perris-Redding. The latter rejoined the Team ...

Lilly Endowment Community Scholarship application will open through the Johnson County Community Foundation on Aug. 1.

David Mooney, who most recently served as Chief of Cyber Protective Services at the Cybersecurity and Infrastructure Security ...

LLY's explosive growth from Mounjaro and Zepbound outpaces MRK's Keytruda-led gains, despite valuation concerns.

Penn's Kiran Musunuru spoke with The Inquirer about the future of CRISPR technology.

President Trump has threatened to levy tariffs of up to 200% on pharmaceutical imports. Lilly's margins could be negatively ...

Eli Lilly's weight loss drugs, especially Zepbound and Mounjaro, have driven impressive revenue growth. Click here to read an ...